Skip to main content
Apeloa Pharmaceutical Co.,Ltd. logo

Apeloa Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 000739 ISIN · CNE000000Q45 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,841 across all filing types
Latest filing 2022-03-09 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 000739

About Apeloa Pharmaceutical Co.,Ltd.

https://www.apeloa.com

Apeloa Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and distribution of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. The company operates three core business pillars: API production, Contract Development and Manufacturing Organization (CDMO) services, and finished drug products. Its therapeutic focus includes cardiovascular, anti-infective, anti-viral, and oncology treatments. Apeloa utilizes an integrated supply chain to deliver chemical and biological solutions to a global client base. The organization maintains compliance with international quality standards, including certifications from the FDA, EMA, and PMDA. Its CDMO services encompass the full product lifecycle, from process chemistry and analytical development to large-scale commercial manufacturing, supported by specialized technology platforms such as continuous flow chemistry and enzymatic synthesis.

Recent filings

Filing Released Lang Actions
信息披露事务管理制度
Governance Information Classification · 95% confidence The document is a detailed internal policy titled '信息披露事务管理制度' (Information Disclosure Management System) of 普洛药业股份有限公司. It outlines the company's procedures, responsibilities, and rules for information disclosure, including definitions of periodic reports (annual, semi-annual, quarterly), temporary reports, confidentiality, internal controls, and investor relations activities. It does not contain actual financial data, financial statements, audit opinions, or earnings results. Instead, it is a governance document describing how the company manages and controls its information disclosure obligations in compliance with regulatory requirements. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2022-03-09 Chinese
监事会议事规则
Governance Information Classification · 95% confidence The document is titled '监事会议事规则' which translates to 'Supervisory Board Meeting Rules' for 普洛药业股份有限公司. It details the rules and procedures for the supervisory board meetings, including their powers, meeting convocations, voting procedures, and record-keeping. There is no financial data, no report or announcement of financial results, no mention of annual or interim reports, no voting results, no management changes, no legal proceedings, no capital updates, and no investor presentations. The document is a governance-related internal rules document outlining the supervisory board's operational framework. Therefore, it fits best under Governance Information (CGR). The document length is 2614 characters, which is consistent with a detailed governance document rather than a brief announcement or a full financial report.
2022-03-09 Chinese
公司章程
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of 普洛药业股份有限公司 (Apeloa Pharmaceutical Co., Ltd.) dated March 2022. It contains detailed provisions about the company's organization, shareholder rights, board of directors, management, shareholder meetings, voting procedures, capital structure, and other governance-related rules. It references Chinese company law and securities law, and extensively covers governance topics such as shareholder meetings, board elections, voting rights, and company operations. There is no indication that this is an annual report, financial statement, audit report, or earnings release. Instead, it is a governance document outlining the internal rules and structure of the company. Therefore, the appropriate classification is Governance Information (CGR). The document length (15,000 characters) and content confirm it is the full governance document, not just an announcement or summary.
2022-03-09 Chinese
内部控制鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled '内部控制审计报告' which translates to 'Internal Control Audit Report'. It is issued by an accounting firm and addresses the audit of the effectiveness of internal controls over financial reporting as of December 31, 2021. The content includes the auditor's responsibilities, the company's responsibilities, inherent limitations of internal control, and the auditor's opinion on the effectiveness of internal controls. This matches the description of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles. The document is not a full annual report, nor is it a brief announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2021
2022-03-09 Chinese
关于公司2021年度日常关联交易实际情况与预计存在差异事项的专项意见
Audit Report / Information Classification · 95% confidence The document is a special opinion from independent directors regarding the actual situation and forecast differences of the company's 2021 related party transactions. It references regulatory rules from the China Securities Regulatory Commission and Shenzhen Stock Exchange, and discusses the differences between forecasted and actual related party transactions for the fiscal year 2021. The document is a formal opinion on audit or compliance matters related to accounting and transactions, but it is not a full annual report or financial statement. It is a standalone audit-related opinion focusing on related party transactions and their fairness, which fits the category of Audit Report / Information (AR). The document length is short and contains detailed analysis and opinion rather than just an announcement or certification, so it is not RPA or RNS. Therefore, the best classification is AR with high confidence. FY 2021
2022-03-09 Chinese
关联交易决策制度
Governance Information Classification · 95% confidence The document is titled '关联交易决策制度' which translates to 'Related Party Transaction Decision System'. It outlines the company's policies, procedures, and governance regarding related party transactions, including definitions, decision-making processes, disclosure requirements, and regulatory compliance. There are no financial statements, earnings data, or report publication announcements. The content is focused on governance and internal rules related to related party transactions, which fits the Governance Information category. The document length is about 4942 characters, which is sufficient for a detailed governance policy document rather than a brief announcement or certification. Therefore, the most appropriate classification is Governance Information (CGR).
2022-03-09 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.